Innova Captab Limited (INNOVACAP) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Innova Captab Limited stock ₹405, price ₹1,172, that is 65.5% below the price, quality 51 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Innova Captab Limited
INNOVACAP · NSEFar too expensive (fair value 66% below the price), but solid company and rising price: meets 2 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
34‑month range ₹448.22 – ₹1,298 · fair‑value band ₹154.99 – ₹582.21 · the ₹1,172 price screens above the ₹404.95 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.
Every Wednesday you see whether Innova Captab is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies.
Show moreShow less
It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals.
The company sells its branded generic products through a network of distributors and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
Stock analysis
Innova Captab Limited (INNOVACAP) currently trades at ₹1,172, while our model-based Fair Value estimate is ₹404.95, 66% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹749.68 per share, and 0 of the 26 models we run sit above the ₹1,172 price.
Bear case: the Economic Profit group reads lowest at ₹140.93, and 26 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹154.99 (bear) to ₹582.21 (bull), the price of ₹1,172 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Innova Captab Limited reported revenue of ₹16.0B in FY2026 versus ₹8.0B in FY2022, a compound +19.0%/yr. Reported net income was ₹1.4B in FY2026, compounding +21.8%/yr from FY2022.
Key figures
Market cap ₹67.1B (≈ $712M) Small · P/E ratio 43.6 · P/S ratio 3.83 · EPS (TTM) ₹26.91 · Dividend yield 0.3% · Net margin 8.8% · Return on equity 13.8% · Return on assets (EBIT) 13.0% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 10% below its 52-week high and 82% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −66%, INNOVACAP screens richer than that median.
Fair Value models
All 26 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
INNOVACAP screens overvalued: fair value 66% below the price. Compare with Merck KGaA →
Compare Innova Captab Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 605 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Price/FCF by industry
- Debt-to-equity by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs INNOVACAP |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs INNOVACAP |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs INNOVACAP |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs INNOVACAP |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs INNOVACAP |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs INNOVACAP |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs INNOVACAP |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs INNOVACAP |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs INNOVACAP |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs INNOVACAP |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Innova Captab Limited (INNOVACAP) overvalued or undervalued?
What is the fair value of INNOVACAP?
What is the quality score of INNOVACAP?
What is the price target for Innova Captab Limited (INNOVACAP)?
What is the Innova Captab Limited stock forecast for 2026?
What is the revenue of Innova Captab Limited (INNOVACAP)?
Does Innova Captab Limited pay a dividend?
How much is the dividend of Innova Captab Limited (INNOVACAP) and when is the ex-dividend date?
What growth is priced into Innova Captab Limited (INNOVACAP)?
What discount rate (WACC) does the fair value of INNOVACAP use?
What is a reverse DCF?
How much growth has Innova Captab Limited (INNOVACAP) delivered so far?
How fast is the sector of Innova Captab Limited (INNOVACAP) growing?
What is the free cash flow yield of Innova Captab Limited (INNOVACAP)?
What is the intrinsic value of Innova Captab Limited (INNOVACAP)?
Is Innova Captab Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of INNOVACAP?
How much is Innova Captab Limited worth?
What do the bullish and bearish scenarios say about INNOVACAP?
What is the P/E ratio of INNOVACAP?
How solid is the balance sheet of Innova Captab Limited (INNOVACAP)?
How far is INNOVACAP from its 52-week high?
Which stocks are comparable to Innova Captab Limited?
Is Innova Captab Limited stock attractive at the current price?
How is the fair value of INNOVACAP calculated?
Is it still worth investing in stocks now?
What is the share price of Innova Captab Limited (INNOVACAP)?
What should I pay attention to with Innova Captab Limited right now?
Key figures of Innova Captab Limited
How large is the market capitalisation of Innova Captab Limited (INNOVACAP)?
What is the P/S ratio of Innova Captab Limited (INNOVACAP)?
What are the earnings per share of Innova Captab Limited (INNOVACAP)?
What is the dividend yield of Innova Captab Limited (INNOVACAP)?
What is the net margin of Innova Captab Limited (INNOVACAP)?
What is the return on equity of Innova Captab Limited (INNOVACAP)?
What is the EBIT return on assets of Innova Captab Limited (INNOVACAP)?
What is the operating margin of Innova Captab Limited (INNOVACAP)?
How fast is revenue growing at Innova Captab Limited (INNOVACAP)?
How fast are earnings growing at Innova Captab Limited (INNOVACAP)?
How much net debt does Innova Captab Limited (INNOVACAP) carry?
Watch Innova Captab Limited in the live analysis
One click puts Innova Captab Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.